FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1965891567> ?p ?o ?g. }

• W1965891567 endingPage "12330" @default.
• W1965891567 startingPage "12325" @default.
• W1965891567 abstract "Pancreatic ductal adenocarcinoma (PDA) is characterized by abundant desmoplasia and poor tissue perfusion. These features are proposed to limit the access of therapies to neoplastic cells and blunt treatment efficacy. Indeed, several agents that target the PDA tumor microenvironment promote concomitant chemotherapy delivery and increased antineoplastic response in murine models of PDA. Prior studies could not determine whether chemotherapy delivery or microenvironment modulation per se were the dominant features in treatment response, and such information could guide the optimal translation of these preclinical findings to patients. To distinguish between these possibilities, we used a chemical inhibitor of cytidine deaminase to stabilize and thereby artificially elevate gemcitabine levels in murine PDA tumors without disrupting the tumor microenvironment. Additionally, we used the FG-3019 monoclonal antibody (mAb) that is directed against the pleiotropic matricellular signaling protein connective tissue growth factor (CTGF/CCN2). Inhibition of cytidine deaminase raised the levels of activated gemcitabine within PDA tumors without stimulating neoplastic cell killing or decreasing the growth of tumors, whereas FG-3019 increased PDA cell killing and led to a dramatic tumor response without altering gemcitabine delivery. The response to FG-3019 correlated with the decreased expression of a previously described promoter of PDA chemotherapy resistance, the X-linked inhibitor of apoptosis protein. Therefore, alterations in survival cues following targeting of tumor microenvironmental factors may play an important role in treatment responses in animal models, and by extension in PDA patients." @default.
• W1965891567 created "2016-06-24" @default.
• W1965891567 creator A5014477435 @default.
• W1965891567 creator A5014489598 @default.
• W1965891567 creator A5014951457 @default.
• W1965891567 creator A5023473145 @default.
• W1965891567 creator A5033719663 @default.
• W1965891567 creator A5041621307 @default.
• W1965891567 creator A5067042593 @default.
• W1965891567 creator A5071360446 @default.
• W1965891567 creator A5072185005 @default.
• W1965891567 creator A5089482204 @default.
• W1965891567 date "2013-07-08" @default.
• W1965891567 modified "2023-10-18" @default.
• W1965891567 title "CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer" @default.
• W1965891567 cites W134625928 @default.
• W1965891567 cites W1557686543 @default.
• W1965891567 cites W1931508686 @default.
• W1965891567 cites W1973554995 @default.
• W1965891567 cites W1975153720 @default.
• W1965891567 cites W1975501741 @default.
• W1965891567 cites W1992995822 @default.
• W1965891567 cites W2006077720 @default.
• W1965891567 cites W2014326933 @default.
• W1965891567 cites W2014434319 @default.
• W1965891567 cites W2019214567 @default.
• W1965891567 cites W2022057988 @default.
• W1965891567 cites W2029437176 @default.
• W1965891567 cites W2032830044 @default.
• W1965891567 cites W2033941781 @default.
• W1965891567 cites W2040560614 @default.
• W1965891567 cites W2043991982 @default.
• W1965891567 cites W2047063453 @default.
• W1965891567 cites W2055091294 @default.
• W1965891567 cites W2055624262 @default.
• W1965891567 cites W2064757398 @default.
• W1965891567 cites W2075078693 @default.
• W1965891567 cites W2083776086 @default.
• W1965891567 cites W2085588982 @default.
• W1965891567 cites W2099704453 @default.
• W1965891567 cites W2100519108 @default.
• W1965891567 cites W2101063198 @default.
• W1965891567 cites W2103758630 @default.
• W1965891567 cites W2106074488 @default.
• W1965891567 cites W2107441200 @default.
• W1965891567 cites W2109661018 @default.
• W1965891567 cites W2113701382 @default.
• W1965891567 cites W2117692326 @default.
• W1965891567 cites W2122742138 @default.
• W1965891567 cites W2129176863 @default.
• W1965891567 cites W2130464657 @default.
• W1965891567 cites W2131070390 @default.
• W1965891567 cites W2132445818 @default.
• W1965891567 cites W2133341222 @default.
• W1965891567 cites W2140723615 @default.
• W1965891567 cites W2151253787 @default.
• W1965891567 cites W2162424291 @default.
• W1965891567 cites W2165566753 @default.
• W1965891567 cites W2165948908 @default.
• W1965891567 cites W2168467781 @default.
• W1965891567 doi "https://doi.org/10.1073/pnas.1300415110" @default.
• W1965891567 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3725120" @default.
• W1965891567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23836645" @default.
• W1965891567 hasPublicationYear "2013" @default.
• W1965891567 type Work @default.
• W1965891567 sameAs 1965891567 @default.
• W1965891567 citedByCount "201" @default.
• W1965891567 countsByYear W19658915672013 @default.
• W1965891567 countsByYear W19658915672014 @default.
• W1965891567 countsByYear W19658915672015 @default.
• W1965891567 countsByYear W19658915672016 @default.
• W1965891567 countsByYear W19658915672017 @default.
• W1965891567 countsByYear W19658915672018 @default.
• W1965891567 countsByYear W19658915672019 @default.
• W1965891567 countsByYear W19658915672020 @default.
• W1965891567 countsByYear W19658915672021 @default.
• W1965891567 countsByYear W19658915672022 @default.
• W1965891567 countsByYear W19658915672023 @default.
• W1965891567 crossrefType "journal-article" @default.
• W1965891567 hasAuthorship W1965891567A5014477435 @default.
• W1965891567 hasAuthorship W1965891567A5014489598 @default.
• W1965891567 hasAuthorship W1965891567A5014951457 @default.
• W1965891567 hasAuthorship W1965891567A5023473145 @default.
• W1965891567 hasAuthorship W1965891567A5033719663 @default.
• W1965891567 hasAuthorship W1965891567A5041621307 @default.
• W1965891567 hasAuthorship W1965891567A5067042593 @default.
• W1965891567 hasAuthorship W1965891567A5071360446 @default.
• W1965891567 hasAuthorship W1965891567A5072185005 @default.
• W1965891567 hasAuthorship W1965891567A5089482204 @default.
• W1965891567 hasBestOaLocation W19658915671 @default.
• W1965891567 hasConcept C121608353 @default.
• W1965891567 hasConcept C126322002 @default.
• W1965891567 hasConcept C142724271 @default.
• W1965891567 hasConcept C159654299 @default.
• W1965891567 hasConcept C170493617 @default.
• W1965891567 hasConcept C203014093 @default.
• W1965891567 hasConcept C2775960820 @default.
• W1965891567 hasConcept C2776107976 @default.

• next